What is TransMedics?
TransMedics is a organ transplant technology company company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- Organ transplant technology company
- Headquarters
- Andover, United States
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: TMDX
What is TransMedics?
TransMedics is a organ transplant technology company company headquartered in Andover, United States. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
TransMedics is a organ transplant technology company company headquartered in Andover, United States. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, TransMedics should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does TransMedics offer?
TransMedics's profile centers on Organ perfusion, Transplant logistics, Medical devices, Organ care systems.
- Organ perfusion· Organ transplant technology company
- Transplant logistics· Organ transplant technology company
- Medical devices· Organ transplant technology company
- Organ care systems· Organ transplant technology company
- Clinical support· Organ transplant technology company
- Aviation logistics· Organ transplant technology company
How does TransMedics make money?
TransMedics makes money through commercial activity tied to organ transplant technology company.
TransMedics monetizes through the model common to organ transplant technology company: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads TransMedics?
TransMedics's named executives should be verified on the official leadership or investor-relations page before outreach.
- TransMedics executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- TransMedics finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- TransMedics operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact TransMedics's leadership?
TransMedics should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.transmedics.com- TransMedics investor relationsInvestor relations / corporate contactcontact via https://www.transmedics.com
- TransMedics media relationsMedia or communications contact routecontact via https://www.transmedics.com
How is TransMedics funded?
TransMedics's current status is Public company; Nasdaq: TMDX.
TransMedics's capital profile is best understood through its current public-company status: Public company; Nasdaq: TMDX. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did TransMedics get here?
TransMedics's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingTransMedics is foundedThe company begins building in organ transplant technology company.
- Scale-upCommercial footprint expandsTransMedics broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq: TMDXPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are TransMedics's competitors?
TransMedics competes with larger incumbents and focused specialists in organ transplant technology company.
TransMedics — frequently asked questions
